Drawing for INTERMOUNTAIN HEALTH LEADERSHIP INSTITUTE

USPTO serial 86958459

INTERMOUNTAIN HEALTH LEADERSHIP INSTITUTE

Reviewed by CopyMark Law Group

Reg. 5590699Status 702Registered
Filing date
Status date
Registration date
Oct 23, 2018
Examiner
FRISCH, HANNA CHO
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with INTERMOUNTAIN HEALTH LEADERSHIP INSTITUTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua G. Gigger

Joshua G. Gigger STOEL RIVES LLP201 SOUTH MAIN STREET, SUITE 205ONE UTAH CENTERSALT LAKE CITY, UT 84111

Goods and services

ClassDescriptionStatusFirst use
035Consulting services in the field of medical practice management for others in the fields of allergy and immunology, anesthesiology, dermatology, emergency medicine, family medicine, internal medicine, medical genetics, neurology, nuclear medicine, obstetrics and gynecology, orthopedics, otolaryngology, pediatrics, physical medicine and rehabilitation, psychiatry, oncology, radiology, surgery, urology; medical cost management; promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare; promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; business consulting and management in the field of clinical trials, namely, providing information management services; business consultation in the field of medical leadership development and medical business management; management consulting and advisory services in the areas of corporate growth strategy, innovation and growth processes, organizational transformation, and talent management and development strategies in the medical field; providing information in the fields of business innovation process, business management and business opportunities in the medical field; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug and medical device approval; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; providing independent review of clinical trials for business purposes; business services provided to the healthcare industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; consulting in the fields of healthcare operations management and hospital operations management; and consulting services in the field of patient relationship management for healthcare providersACTIVEMay 15, 2018
041Consulting services in the field of medical education, namely, providing education and training information relating to the identification, diagnosis and treatment of medical and genetic conditions and providing advice relating to the development of educational curriculum in the field of medicine; continuing education services, namely, providing live and on-line continuing professional education seminars in the medical field; medical training and teaching; publishing and issuing scientific papers in relation to medical technology; business education and training services, namely, developing customized leadership and executive development programs, providing executive coaching services, and providing business education programs to employees and executives in the medical field; educational services, namely, providing a learning and innovation center featuring fully customized leadership, motivational, educational, and brainstorming training in the medical field; and leadership development training in the field of medicineACTIVEMay 15, 2018
044Consulting services in the field of medical care; providing medical information, consultancy and advisory services; providing medical information in the medical field; providing medical information in the form of reports in the medical field; and providing healthcare informationACTIVEMay 15, 2018

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2025NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Oct 7, 2025A7OKAMENDMENT UNDER SECTION 7 - PROCESSED—
Sep 19, 2025WDRLOTQR WITHDRAWAL FROM PUBLICATION—
Jul 31, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 31, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 31, 2025XXXXPOST REGISTRATION ACTION CORRECTION—
Jun 10, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Mar 15, 2025PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Mar 10, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 21, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Oct 10, 2024ES7RTEAS SECTION 7 REQUEST RECEIVED—
Oct 23, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 23, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 18, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 17, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 22, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 20, 2018IUAFUSE AMENDMENT FILED—
Aug 20, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 30, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 29, 2018EX3GSOU EXTENSION 3 GRANTED—
Jan 26, 2018EXT3SOU EXTENSION 3 FILED—
Jan 26, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 4, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 3, 2017EX2GSOU EXTENSION 2 GRANTED—
Aug 3, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 27, 2017EXT2SOU EXTENSION 2 FILED—
Jul 27, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 6, 2017EX1GSOU EXTENSION 1 GRANTED—
Mar 6, 2017EXT1SOU EXTENSION 1 FILED—
Mar 6, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 20, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 26, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 26, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 6, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 17, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 10, 2016ALIEASSIGNED TO LIE—
May 31, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 31, 2016XAECEXAMINER'S AMENDMENT ENTERED—
May 31, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 31, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
May 31, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
May 27, 2016DOCKASSIGNED TO EXAMINER—
Apr 5, 2016MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 4, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance